Joseph Vazzano
Direttore Finanziario/CFO presso ABEONA THERAPEUTICS INC.
Patrimonio netto: 952 475 $ in data 31/05/2024
Posizioni attive di Joseph Vazzano
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Comptroller/Controller/Auditor | 31/03/2022 | - |
| Direttore Finanziario/CFO | 14/03/2022 | - | |
| ALLARITY THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/08/2023 | - |
| Independent Dir/Board Member | 01/08/2023 | - | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Direttore/Membro del Consiglio | - | - |
| Independent Dir/Board Member | - | - |
Storia della carriera di Joseph Vazzano
Precedenti posizioni note di Joseph Vazzano
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AVENUE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15/08/2017 | 08/02/2019 |
| Direttore Finanziario/CFO | 15/08/2017 | 07/01/2022 | |
| Segretario Aziendale | 08/02/2019 | 07/01/2022 | |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2016 | 01/07/2017 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
| Pernix Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Formazione di Joseph Vazzano
| Lehigh University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| 2 | |
| Danimarca | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| AVENUE THERAPEUTICS, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Pernix Therapeutics, Inc. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Joseph Vazzano
- Esperienza
